XRAY

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors

Retrieved on: 
Thursday, February 29, 2024

CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election.

Key Points: 
  • CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election.
  • Mr. Brandt commented, “As I think back on the past two decades and all of the challenges we’ve navigated together, I am grateful for the talented and dedicated individuals with whom I have had the privilege to serve.
  • I am proud of the strong and diverse Board that we have assembled and I believe it's the right time for me to step aside.
  • His unwavering support and guidance, and insightful contributions have been instrumental in shaping the Company’s future.

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend

Retrieved on: 
Thursday, February 29, 2024

Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compared to the full year of 2022.

Key Points: 
  • Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compared to the full year of 2022.
  • Fourth quarter net sales of $1,012 million increased 2.9% (organic sales increased 1.9%) compared to the fourth quarter of 2022.
  • Net income was $67 million, or $0.32 per diluted share, compared to net income (loss) of ($15) million, or ($0.07) per share in the fourth quarter of 2022.
  • Adjusted earnings per diluted share were $0.44 compared to $0.46 in the fourth quarter of 2022.

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th

Retrieved on: 
Monday, January 29, 2024

CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results.

Key Points: 
  • CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results.
  • A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com .
  • A live webcast will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com .
  • A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results

Retrieved on: 
Tuesday, January 9, 2024

CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).

Key Points: 
  • CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).
  • As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company’s previously provided outlook range of $3.90 billion to $3.94 billion.
  • The Company is reaffirming its full year 2023 adjusted EPS outlook range of $1.80 to $1.85 and its expectations for double-digit adjusted EPS growth in 2024.
  • The preliminary estimates above are based solely upon information available to management as of the date of this press release and are subject to change.

Dentsply Sirona to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 3, 2024

Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
  • Management is scheduled to present on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).
  • Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.

Dentsply Sirona Declares Quarterly Cash Dividend

Retrieved on: 
Thursday, December 21, 2023

CHARLOTTE, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share.

Key Points: 
  • CHARLOTTE, N.C., Dec. 21, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share.
  • The dividend is payable on January 12, 2024, to holders of record as of December 29, 2023.

Dentsply Sirona to Participate in Upcoming Investor Conferences

Retrieved on: 
Friday, November 10, 2023

CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Key Points: 
  • CHARLOTTE, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
  • Jefferies 2023 London Healthcare Conference on November 15, 2023, at 8:30 am GMT
    6th Annual Evercore ISI HealthCONx Conference on November 29, 2023, at 8:00 am ET
    Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host its Investor Day and Introduce Three-Year Financial Targets

Retrieved on: 
Thursday, November 9, 2023

CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host its Investor Day today at the Company’s headquarters in Charlotte, N.C.

Key Points: 
  • CHARLOTTE, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will host its Investor Day today at the Company’s headquarters in Charlotte, N.C.
  • The event will include presentations from members of its executive management team, live Q&A, and panel discussions with commercial leaders and customers.
  • As part of the event, the Company will introduce three-year financial targets including details of its plan to achieve adjusted EPS of $3.00 in 2026.
  • The Company is also announcing that its Board of Directors has authorized an additional $1 billion share repurchase program.

Dentsply Sirona Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 2, 2023

Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%)

Key Points: 
  • Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%)
    CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2023.
  • Third quarter net sales of $947 million were flat (organic sales decreased (0.3%)) compared to the third quarter of 2022.
  • Net loss for the third quarter of 2023 was ($266) million, or ($1.25) per share, compared to net loss of ($1,077) million, or ($5.01) per share in the third quarter of 2022.
  • "Despite the challenging external environment which negatively impacted sales results in the quarter, we delivered over 18% adjusted EBITDA margin and 20% adjusted EPS growth.

Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member

Retrieved on: 
Thursday, November 2, 2023

CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023.

Key Points: 
  • CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the “Board”), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.’s retirement on December 31, 2023.
  • “On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Brian Gladden to the Board,” said Eric K. Brandt, Non-Executive Chairman of the Board.
  • “Brian brings more than 35 years of experience with a proven track record in setting strategic vision, building world-class organizations, and driving business growth and transformation.
  • As a CFO, Mr. Gladden has led all aspects of the finance function, M&A, information technology, security, facilities, and corporate strategy.